Home › Research › Inflammation and the immune system
Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer's Disease: A Systematic Review
Gruendler R, Hippe B, Sendula Jengic V, Peterlin B, Haslberger AG.. Molecules (Basel, Switzerland), 2020-12-18
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Aging and the emergence of age-associated illnesses are one of the major challenges of our present society. Alzheimer's disease (AD) is closely associated with aging and is defined by increasing memory loss and severe dementia. Currently, there are no therapy options available that halt AD progression. This work investigates three hallmarks of the disease (autophagy, neuroinflammation, and senescence) and systematically analyzes if there is a beneficial effect from three substances derived from food sources, the so called "nutraceuticals" epigallocatechin gallate, fisetin, and spermidine, on these hallmarks. The results imply a positive outlook for the reviewed substances to qualify as a novel treatment option for AD. A combination of nutraceutical substances and other preventive measures could have significant clinical impact in a multi-layered therapy approach to counter AD.
What this study adds
Evidence grade: Low
This is a pooled review. This systematic review examined whether three food-derived substances, epigallocatechin gallate, fisetin and spermidine, help with three hallmarks of Alzheimer's: autophagy (the cell's clean-up system), neuroinflammation and cell ageing (senescence). The authors conclude the evidence gives a positive outlook for these substances as a possible new treatment option, perhaps combined with other preventive measures.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Gruendler, R., Hippe, B., Sendula Jengic, V., Peterlin, B., & Haslberger, A. G. (2020). Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer's Disease: A Systematic Review. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules25246018
Vancouver
Gruendler R, Hippe B, Sendula Jengic V, Peterlin B, Haslberger AG. Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer's Disease: A Systematic Review. Molecules (Basel, Switzerland). 2020. doi:10.3390/molecules25246018. PMID: 33353228.
BibTeX
@article{gruendler2020-33353228,
author = {Gruendler, R. and Hippe, B. and Sendula Jengic, V. and Peterlin, B. and Haslberger, A. G.},
title = {{Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer's Disease: A Systematic Review}},
journal = {Molecules (Basel, Switzerland)},
year = {2020},
doi = {10.3390/molecules25246018},
pmid = {33353228},
url = {https://doi.org/10.3390/molecules25246018}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Alzheimer's disease (AD) is closely associated with aging and is defined by increasing memory loss and severe dementia.
- The results imply a positive outlook for the reviewed substances to qualify as a novel treatment option for AD.
- A combination of nutraceutical substances and other preventive measures could have significant clinical impact in a multi-layered therapy approach to counter AD.
Why it matters
This systematic review examined whether three food-derived substances, epigallocatechin gallate, fisetin and spermidine, help with three hallmarks of Alzheimer's: autophagy (the cell's clean-up system), neuroinflammation and cell ageing (senescence). The authors conclude the evidence gives a positive outlook for these substances as a possible new treatment option, perhaps combined with other preventive measures. They present them as candidates for a multi-layered approach, not as established therapies.
Study details
- Study designsystematic review
- Evidence strengthLow
How this study scored 53/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Molecules (Basel, Switzerland)) |
| Journal's citation record | 3 / 4 | Molecules: journal h-index 349 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 4 / 7 | Cited 45 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.6 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 2 / 6 | Cited 1.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 17 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Alexander G. Haslberger: h-index 41 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Vienna: institution h-index 851 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33353228) |
| Free to read | 2 / 2 | Free to read |
| Total | 53 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Inflammation and the immune system from nearby years
Also in Inflammation and the immune system
138 studies in the library are filed under Inflammation and the immune system with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Inflammation and the immune system hub.